van der Weyden, C A
Pileri, S A
Feldman, A L
Whisstock, J
Prince, H M
Article History
Received: 28 April 2017
Revised: 17 July 2017
Accepted: 20 July 2017
First Online: 8 September 2017
Competing interests
: SAP is a member of the speaker bureau for Takeda Pharmaceutical Company and Seattle Genetics. HMP is an Advisory Board Member and has received research support from Takeda Pharmaceutical Company. The remaining authors declare no conflict of interest.